Further underscoring the potential relevance of these sites in intrinsic entry inhibitor sensitivity, treatment of HIV-infected hu-PBL-SCID mice with the CCL5 analog NNY-RANTES selected for mutation at position 318 in the challenge virus, suggesting a potential role of this polymorphism in escape [154].
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}